A Type 2 diabetes medication called lixisenatide appeared to slow the progression of Parkinson’s disease symptoms in a small, mid-stage trial funded by...
Rivals national recruiting analyst Adam Friedman has thoughts on big upcoming commitments, key visits by top prospects and the top ACC quarterbacks next...
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Expectations of wage growth in...
On behalf of Climate Generation, an organization in Minnesota working with high school youth and educators, we are expressing our disappointment in your...
